Alessio Aghemo (A Aghemo)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 44

Top Topics

Roux En Y Gastric Bypass

Artificial Intelligence

Chronic Kidney Disease

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

European journal of nuclear medicine and molecular imaging

Expert review of gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Roberta D'Ambrosio, Maria P Anolli, Nicola Pugliese, Chiara Masetti, Alessio Aghemo, Pietro Lampertico
Prevalence of HCV infection in Europe in the DAA era: Review. Liver international : official journal of the International Association for the Study of the Liver (2024)
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Abhi Bhagat, Valentina Gallinaro, Giuliana Gualberti, Rocco Cosimo Damiano Merolla, Antonio Gasbarrini
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. PloS one 18 (2) (2023)
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Abhi Bhagat, Valentina Gallinaro, Giuliana Gualberti, Rocco Cosimo Damiano Merolla, Antonio Gasbarrini
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. PloS one 18 (2) (2023)
Luca Vittorio Valenti, Alessio Aghemo, Alejandro Forner, Salvatore Petta, Stefano Romeo, Pierre Nahon
Measuring the impact of the updated Steatotic liver disease nomenclature and definition. Liver international : official journal of the International Association for the Study of the Liver 43 (11) (2023)
Alessio Aghemo, Alejandro Forner, Luca Vittorio Valenti
Should Artificial Intelligence-based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International. Liver international : official journal of the International Association for the Study of the Liver 43 (5) (2023)
Nicola Pugliese, Vincenza Calvaruso, Mario Masarone, Roberta D'Ambrosio, Sara Battistella, Anna Licata, Marcello Persico, Maria Paola Anolli, Marco Distefano, Salvatore Petta, Francesco Paolo Russo, Vito Di Marco, Alessio Aghemo
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Alessio Aghemo, Alejandro Forner, Luca Vittorio Valenti
Should Artificial Intelligence-based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International. Liver international : official journal of the International Association for the Study of the Liver 43 (5) (2023)
Loreta A Kondili, Massimo Andreoni, Alessio Aghemo, Claudio Maria Mastroianni, Rocco Merolla, Valentina Gallinaro, Gianpiero D'Offizi, Antonio Craxì
Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach. Liver international : official journal of the International Association for the Study of the Liver (2023)
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Abhi Bhagat, Valentina Gallinaro, Giuliana Gualberti, Rocco Cosimo Damiano Merolla, Antonio Gasbarrini
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. PloS one 18 (2) (2023)
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Abhi Bhagat, Valentina Gallinaro, Giuliana Gualberti, Rocco Cosimo Damiano Merolla, Antonio Gasbarrini
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study. PloS one 18 (2) (2023)
Heiner Wedemeyer, Tammo L Tergast, Jeffrey Victor Lazarus, Homie Razavi, Kostas Bakoyannis, Ricardo Baptista-Leite, Marco Bartoli, Philip Bruggmann, Cristian-Silviu Buşoi, Maria Buti, Manuel Carballo, Laurent Castera, Massimo Colombo, Rodrigo Sousa Coutinho, Yuval Dadon, Gamal Esmat, Rafael Esteban, Joan Colom Farran, Mark Gillyon-Powell, David Goldberg, Sharon Hutchinson, Harry L A Janssen, George Kalamitsis, Loreta A Kondili, John S Lambert, Rui Tato Marinho, Mojca Maticic, Aldo Patricello, Markus Peck-Radosavljevic, Stanislas Pol, Mario Poljak, Cora Pop, Tomislov Sokol, Vana Sypsa, Nurdan Tözün, Zobair M Younossi, Alessio Aghemo, Georgios Papatheodoridis, Angelos Hatzakis
Securing Wider EU Commitment to the Elimination of HCV. Liver international : official journal of the International Association for the Study of the Liver (2022)
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo
Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert review of gastroenterology & hepatology 17 (1) (2022)
Gianluca Franchellucci, Maria Terrin, Alessio Aghemo, Nicola Pugliese
Liver biopsy is associated with increased body weight loss in patients with non-alcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo
Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert review of gastroenterology & hepatology 17 (1) (2022)
Chiara Masetti, Francesca Colapietro, Antonio Voza, Alessio Aghemo
No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Nicola Pugliese, Luca di Tommaso, Ana Lleo, Ludovico Alfarone, Elisabetta Mastrorocco, Maria Terrin, Roberto Ceriani, Francesca Colapietro, Luigi Terracciano, Alessio Aghemo
High prevalence of porto-sinusoidal vascular disease in patients with constantly elevated gamma-glutamyl transferase levels. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Chiara Masetti, Francesca Colapietro, Antonio Voza, Alessio Aghemo
No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan. Liver international : official journal of the International Association for the Study of the Liver 42 (11) (2022)
Giulia Mastrorilli, Francesca Fiorentino, Carmen Tucci, Gloria Lombardi, Alessio Aghemo, Giorgio Lorenzo Colombo
Cost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective Procedures. ClinicoEconomics and outcomes research : CEOR 14 (2022)
Francesca Romana Ponziani, Alessio Aghemo, Giuseppe Cabibbo, Mario Masarone, Sara Montagnese, Salvatore Petta, Francesco Paolo Russo, Quirino Lai, null null
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey. Liver international : official journal of the International Association for the Study of the Liver 41 (9) (2021)
Chiara Masetti, Alessio Aghemo
Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction. Liver international : official journal of the International Association for the Study of the Liver 41 (7) (2021)
Martina Sollini, Silvia Morbelli, Michele Ciccarelli, Maurizio Cecconi, Alessio Aghemo, Morelli Paola, Silvia Chiola, Fabrizia Gelardi, Arturo Chiti
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. European journal of nuclear medicine and molecular imaging 48 (10) (2021)
Jörn Markus Schattenberg, Jeffrey Victor Lazarus, Philip N Newsome, Lawrence Serfaty, Alessio Aghemo, Salvador Augustin, Emmanuel A Tsochatzis, Victor De Ledinghen, Elisabetta Bugianesi, Manuel Romero, Heike Bantel, Stephen D Ryder, Jerome Boursier, Vincent Leroy, Javier Crespo, Laurent Castera, Lefteris Floros, Vincenzo Atella, Jorge Mestre-Ferrandiz, Rachel Elliott, Achim Kautz, Alice Morgan, Sally Hartmanis, Sharad Vasudevan, Lynne Pezzullo, Aldo Trylesinski, Sandrine Cure, Victoria Higgins, Vlad Ratziu
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Nicola Pugliese, Maria Corina Plaz Torres, Salvatore Petta, Luca Vittorio Valenti, Edoardo Giovanni Giannini, Alessio Aghemo
Is there an 'ideal' diet for patients with NAFLD? European journal of clinical investigation (2021)
Virginia Solitano, Alessio Aghemo
Sofosbuvir in HCV patients with chronic kidney disease: No time for caution. Liver international : official journal of the International Association for the Study of the Liver 41 (4) (2021)
Francesca Colapietro, Chiara Masetti, Roberto Ceriani, Paola Morelli, Dario Poretti, Vittorio Pedicini, Nicola Pugliese, Antonio Voza, Ana Lleo, Alessio Aghemo
High prevalence of multidrug-resistant bacteria in patients with pyogenic liver abscess following liver cancer loco-regional treatments. Liver international : official journal of the International Association for the Study of the Liver 41 (8) (2021)
Catherine W Spearman, Alessio Aghemo, Luca Vittorio Valenti, Mark W Sonderup
COVID-19 and the liver: A 2021 update. Liver international : official journal of the International Association for the Study of the Liver 41 (9) (2021)
Loreta Anesti Kondili, Loreta A Kondili, Alessio Aghemo
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements. Liver international : official journal of the International Association for the Study of the Liver 41 (4) (2021)
Nicola Pugliese, Ezio Lanza, Alessio Aghemo
Sarcopenia in chronic liver disease: easy to diagnose but hard to treat. Liver international : official journal of the International Association for the Study of the Liver 40 (11) (2021)
Velia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, Gianluca Fiorentino, Martina Milana, Stefania Paolucci, Teresa Pollicino, Giulia Morsica, Mario Starace, Bianca Bruzzone, William Gennari, Valeria Micheli, Katia Yu La Rosa, Luca Foroghi, Vincenza Calvaruso, Ilaria Lenci, Ennio Polilli, Sergio Babudieri, Alessio Aghemo, Giovanni Raimondo, Loredana Sarmati, Nicola Coppola, Caterina Pasquazzi, Fausto Baldanti, Giustino Parruti, Carlo Federico Perno, Mario Angelico, Antonio Craxì, Massimo Andreoni, Francesca Ceccherini-Silberstein, null null
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C. Liver international : official journal of the International Association for the Study of the Liver 41 (8) (2021)
Andrea Marcellusi, Francesco Saverio Mennini, Murad Ruf, Claudio Galli, Alessio Aghemo, Maurizia Rossana Brunetto, Sergio Babudieri, Loreta A Kondili, Massimo Andreoni, Loreta Anesti Kondili
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation. Liver international : official journal of the International Association for the Study of the Liver (2021)
Chiara Masetti, Ana Lleo, Matteo Colombo, Massimo Colombo, Alessio Aghemo
Postsustained Virological Response Management in Hepatitis C Patients. Seminars in liver disease 40 (3) (2020)
Alexandra E Livanos, Divya Jha, Francesca Cossarini, Ana Silvia Gonzalez-Reiche, Minami Tokuyama, Teresa A Aydillo Gomez, Tommaso Lorenzo Parigi, Irene Ramos, Katie Dunleavy, Brian Lee, Rebekah Dixon, Steven T Chen, Gustavo Martinez-Delgado, Satish Nagula, Huaibin Mabel Ko, Benjamin Scott Glicksberg, Girish Nitin Nadkarni, Elisabet Pujadas, Jason Reidy, Steven Naymagon, Ari M Grinspan, Jawad Ahmad, Michael Tankelevich, Ronald Gordon, Keshav Sharma, Jane Houldsworth, Graham J Britton, Alice Chen-Liaw, Matthew P Spindler, Tamar Plitt, Pei Wang, Andrea Cerutti, Jeremiah J Faith, Jean Frederic Colombel, Ephraim Kenigsberg, Carmen A Argmann, Miriam Merad, Sacha Gnjatic, Noam Harpaz, Silvio Danese, Carlos Cordon-Cardo, Adeeb H Rahman, Nikhil A Kumta, Alessio Aghemo, Francesca Petralia, Harm van Bakel, Adolfo García-Sastre, Saurabh Mehandru
Gastrointestinal involvement attenuates COVID-19 severity and mortality. medRxiv : the preprint server for health sciences (2020)
Francesca Colapietro, Alessio Aghemo
Do gamma-glutamyltransferase levels identify HCV patients who require lifelong post-SVR follow-up? Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2020)
Martina Sollini, Michele Ciccarelli, Maurizio Cecconi, Alessio Aghemo, Paola Morelli, Fabrizia Gelardi, Arturo Chiti
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. European journal of nuclear medicine and molecular imaging 48 (5) (2020)
Maria Corina Plaz Torres, Alessio Aghemo
Editorial: should we abandon HCV genotype testing? Maybe. Alimentary pharmacology & therapeutics 49 (8) (2020)
Tommaso Lorenzo Parigi, Alessio Aghemo
HCV screening: Moving from theory to practice. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)
M Persico, Andrea Aglitti, Alessio Aghemo, M Rendina, A Lleo, A Ciancio, Vito Di Marco, Pietro Lampertico, M R Brunetto, M Zuin, Pietro Andreone, E Villa, G Troshina, Vincenza Calvaruso, E Degasperi, B Coco, A Giorgini, F Conti, Alfredo Di Leo, L Marzi, V Boccaccio, S Bollani, P Maisonneuve, Savino Bruno
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. Alimentary pharmacology & therapeutics 47 (12) (2018)